Company C21 Investments Inc Toronto S.E.
Equities
CWQ
CA23129E2069
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabis
100.0
%
| 41 | 100.0 % | 38 | 100.0 % | -8.54% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 38 | 100.0 % | -8.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sonny Newman
CEO | Chief Executive Officer | - | 07/07/19 |
Michael Kidd
DFI | Director of Finance/CFO | - | 25/07/18 |
Aron Swan
COO | Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Macdonald
CHM | Chairman | - | 17/06/18 |
Leonard Werden
BRD | Director/Board Member | - | 24/07/17 |
Michael Kidd
DFI | Director of Finance/CFO | - | 25/07/18 |
Todd Harrison
BRD | Director/Board Member | - | 14/02/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 120,047,814 | 97,526,491 ( 81.24 %) | 0 | 81.24 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+26.93% | 5.55B | |
-33.55% | 3.52B | |
-3.74% | 3.03B | |
-26.09% | 2.59B | |
-10.93% | 2.28B | |
+41.50% | 1.88B | |
+41.84% | 1.46B | |
-12.94% | 1.43B | |
+47.62% | 1.42B |